Compare EVCM & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVCM | TLRY |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | EDP Services | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 2021 | 2018 |
| Metric | EVCM | TLRY |
|---|---|---|
| Price | $9.96 | $7.34 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 3 |
| Target Price | $11.50 | ★ $150.00 |
| AVG Volume (30 Days) | 326.5K | ★ 5.4M |
| Earning Date | 11-06-2025 | 01-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $718,038,000.00 | ★ $830,766,000.00 |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | $5.60 | $4.51 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.13 | 2.31 |
| 52 Week Low | $7.66 | $3.51 |
| 52 Week High | $12.34 | $23.20 |
| Indicator | EVCM | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 57.71 | 85.45 |
| Support Level | $8.47 | $6.90 |
| Resistance Level | $9.01 | $8.98 |
| Average True Range (ATR) | 0.34 | 0.30 |
| MACD | 0.25 | 0.78 |
| Stochastic Oscillator | 100.00 | 79.84 |
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. With a platform serving approximately 708,000 customers across three core verticals, including numerous micro-verticals, their solutions address diverse needs within these sectors. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty. The majority of customers contribute modest revenue, with a small percentage contributing higher amounts.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.